REDWOOD CITY, Calif., March 31 /PRNewswire/ -- Codexis, Inc. today announced Lori Giver, Ph.D., has been named to the new position of Vice President, Systems Biology for Codexis Bioindustrials. She is responsible for cellular engineering, molecular biology, and computational biology. Dr. Giver reports to David Anton, Ph.D., Vice President, Bioindustrials Research and Development.
Dr. Giver is a widely-respected researcher in the directed evolution of genes and proteins. She joined Codexis in 2002 from Maxygen, where she was responsible for biocatalyst discovery and development. At Codexis, she has held a series of scientific leadership roles ranging from Associate Director, Research & Development to her most recent position as Senior Director, Evolution Technology.
She received a bachelor’s degree in molecular and cell biology from the University of California at Berkeley, and a Ph.D. in molecular, cell and developmental biology from Indiana University, Bloomington, where she focused on the directed evolution of nucleic acids with Dr. Andrew Ellington. Dr. Giver did post-doctoral research in directed evolution of proteins at the California Institute of Technology with advisor Dr. Frances Arnold, a pioneer in the field of directed evolution and biocatalysis.
“Lori Giver’s contribution to the development of today’s strong and broad Codexis technology platform has been invaluable,” Dr. Anton said. “She is one of the original core team of scientists that built both our expertise in biocatalysis and our world-class reputation in this field. Her appointment recognizes the role that systems biology, in combination with biocatalysis, will play in finding solutions to the critical need for renewable fuels and future clean technology products. Lori’s advancement to our senior scientific leadership team recognizes her strong personal and professional dedication to our company, to her colleagues, and to finding technology solutions to the major challenges facing our society.”
Codexis, Inc. is a clean technology company. The company develops industrial biocatalysts, including enzymes and microbes. Codexis technology is used in the energy industry to enable next generation, non-food biofuels and by global pharmaceutical companies for cost-effective manufacturing of human therapeutics. Future commercial applications include carbon management, water treatment and chemical manufacturing. For more information, visit www.codexis.com.
Contact: Lyn Christenson, lyn.christenson@codexis.com, 650-421-8144 or Saskia Sidenfaden, ssidenfaden@mww.com, 212-827-3771.
CONTACT: Lyn Christenson of Codexis, Inc., +1-650-421-8144,
lyn.christenson@codexis.com, or Saskia Sidenfaden, +1-212-827-3771,
ssidenfaden@mww.com, for Codexis, Inc.
